NEW YORK, November 17, 2016 /PRNewswire/ --
Healthcare Information Services include software solutions, clinical content, hardware, and devices that provide health care providers secure access to clinical, administrative, and financial data. Today, Stock-Callers.com evaluates the following companies: Cerner Corp. (NASDAQ: CERN), Rennova Health Inc. (NASDAQ: RNVA), Veeva Systems Inc. (NYSE: VEEV), and Inovalon Holdings Inc. (NASDAQ: INOV). Register now and get full and free access to our downloadable research reports on these stocks at: http://stock-callers.com/registration
Missouri headquartered Cerner Corp.'s stock finished Wednesday's session 0.55% lower at $48.93 with a total volume of 4.12 million shares traded. Shares of the Company, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the US and internationally, are trading at a PE ratio of 25.90. The Company's shares are trading below its 50-day and 200-day moving averages by 17.26% and 15.32%, respectively. Cerner's stock has a Relative Strength Index (RSI) of 19.80.
On November 7th, 2016, research firm Bank of America/Merrill downgraded the Company's stock rating from 'Neutral' to 'Underperform'.
On November 14th, 2016, Cerner announced a telehealth agreement with American Well, a leading national telehealth company. Together, the companies will deliver a virtual health care experience that will integrate the American Well platform with Cerner's electronic health record. The integration will enable providers to manage the health and care of patients beyond the walls of the health system. Access our complete research report on CERN for free at: http://stock-callers.com/registration/?symbol=CERN
Florida headquartered Rennova Health Inc.'s stock declined 14.30%, to close the day at $0.08. The stock recorded a trading volume of 1.17 million shares, which was above its three months average volume of 853,860 shares. Shares of the Company, which provides diagnostics and supportive software solutions to healthcare providers, are trading 53.97% and 83.42% below its 50-day and 200-day moving averages, respectively. Additionally, the stock is trading at a PE ratio of 0.16 and has an RSI of 24.47.
On November 14th, 2016, Rennova reported that net revenues for Q3 2016 were $0.3 million compared to $5.9 million for Q3 2015. The Company reported other income of $0.6 million for Q3 2016 compared to other expense of $0.4 million for Q3 2015. Net loss attributed to common stockholders for Q3 2016 was $12.0 million, or $0.29 per basic and diluted share, compared to a net loss attributable to common stockholders for Q3 2015 of $1.5 million, or $0.05 per basic and diluted share. The complimentary research report on RNVA can be downloaded at: http://stock-callers.com/registration/?symbol=RNVA
On Wednesday, shares in California headquartered Veeva Systems Inc. ended the session 0.20% lower at $40.74 with a total volume of 703,182 shares traded. Veeva Systems' shares have advanced 5.96% in the last one month and 2.57% in the previous three months. Further, the stock has surged 48.36% in the past one year. Shares of the Company are trading at a PE ratio of 105.27. The stock is trading 2.86% above its 50-day moving average and 23.61% above its 200-day moving average. Moreover, shares of the Company have an RSI of 62.36.
On November 3rd, 2016, Veeva Systems announced that it will report financial results for its fiscal third quarter which ended October 31st, 2016, after market close on November 22nd, 2016. Veeva will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results. Register for free on Stock-Callers.com and get access to the latest PDF format report on VEEV at: http://stock-callers.com/registration/?symbol=VEEV
On Wednesday, shares in Maryland headquartered Inovalon Holdings Inc. recorded a trading volume of 275,708 shares. The stock ended the day 0.32% lower at $15.55. Shares of the Company, which provides cloud-based data analytics and data-driven intervention platforms in the US, are trading at a PE ratio of 55.94. Inovalon Holdings' stock has gained 9.51% in the last one month and 3.94% in the previous three months. The Company is trading above its 50-day moving average by 4.78%. Furthermore, shares of Inovalon Holdings have an RSI of 62.54.
On October 25th, 2016, research firm First Analysis Sec initiated an 'Equal-Weight' rating on the Company's stock, issuing a target price of $14 per share.
On November 8th, 2016, Inovalon announced that clients utilizing Inovalon's integrated quality measurement and improvement platform, Quality Spectrum™, realized a material positive increase in their Centers for Medicare & Medicaid Services Five-Star Quality Ratings when compared to organizations not utilizing Inovalon technologies. In aggregate, Inovalon clients utilizing the Quality Spectrum™ platform saw an increase in their raw score of 0.16 over their 2016 Star Ratings, yielding an average increase of one half star in their overall 2017 Star Rating. Download your free research report on INOV at: http://stock-callers.com/registration/?symbol=INOV
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://stock-callers.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA